Dedalus NHS Humber EPR implementation is underway after NHS Humber Health Partnership selected...
NEWS
Interim Phase 2 data show functional improvement with IMM01-STEM...
Immunis has reported interim Phase 2 clinical data showing improvements in physical function among...
Wave Life Sciences 2026 strategic priorities accelerate WVE-007...
Wave Life Sciences 2026 strategic priorities were outlined by the company at the 44th Annual J.P...
Novartis ianalumab receives FDA Breakthrough Therapy designation...
Novartis has received US Food and Drug Administration Breakthrough Therapy designation for...

